Whitepapers
Pharma white papers on contemporary issues, technologies, research, etc. are presented in this section to enable the readers with rich information and knowledge. This section provides white papers related to all the spheres of the pharma industry.
Guidance On GenAI Adoption For Pharma Leaders
The pharmaceutical industry is on the brink of a revolutionary transformation with the advent of Generative Artificial Intelligence GenAI This whitepaper aims to provide pharma leaders with a comprehensive guide on adopting GenAI technologies It covers the potential applications benefits challenges
Agentic AI in Life Sciences
Life sciences companies are facing mounting pressure to make quicker more impactful decisions in environments that are highly complex and tightly regulated While traditional AI and Generative AI have made strides in automating routine tasks like drafting documents or assessing risks their benefits have been mostly limited to isolated oneoff scenarios
Risk Management of Building Personnel Expertise While Starting and Growing Cell and Gene Therapy Biotechnology Companies
The cell and gene therapy CGT industry is revolutionizing medicine with therapies capable of treating rare and lifethreatening diseases However launching and scaling a CGT biotech company involves navigating complex risksparticularly those associated with building personnel expertise
Navigating EMA PMS Requirements: A Strategic Guide for Regulatory Leaders
By IDMP compliance will become drastically more challenging for all pharmaceutical companies operating in the EU due to the broader adoption of the IDMP data model The EMA Product Management Services PMS Requirements present a strategic opportunity not just another regulatory burden This whitepaper provides actionable insights for regulatory leaders to streamline compliance enhance efficiency and...
Design Space of Robust Analytical Methods in the Pharmaceutical Environment
In the pharmaceutical industry significant paradigm shifts are transforming the quality environment to support modern and innovative manufacturing Regulators industry leaders and standardssetting organizations are increasingly emphasizing riskbased and Quality by Design QbD approaches over traditional compliancedriven and qualitybytesting methods
Pharmaceutical Disruption: Are Compounding Pharmacies a Friend or Foe?
In the dynamic landscape of drug development and distribution compounding pharmacies have come to play an important role in addressing unique patient needs However their presence in the market can also disrupt traditional pharmaceutical models as recent controversies have shown And while they may not directly participate in drug development
Precision Automation Technologies that Minimize Laser-Cut Hypotube Manufacturing Risk
Lasercut hypotubes LCHTs enable minimally invasive procedures across a range of medical applications However producing them in high volumes presents significant challenges largely due to the precision required in their manufacture Precision automation technologies that minimize LCHT manufacturing risks are reshaping the industry
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment a significant portion of work is conducted using computerized systems Many solutions are used to complete tasks including simple desktop programs like email and Microsoft Office to enterprisewide global systems like ERP Enterprise Resource Planning MES Manufacturing Execution System and LIMS
Harness the Power of Generative AI in Pharma: Accelerate Drug Discovery and Development
This advancement in technology is revolutionizing various stages of drug discovery and development from initial research to clinical trials and regulatory submissions By leveraging GenAI pharmaceutical companies have accelerated the drug development process reduced costs and improved the accuracy and efficiency of regulatory documentation
Reimagining FSP with ProPharma’s RCO Model
Functional Service Providers FSPs evolved from the landscape of fullservice and businessprocess outsourcing FSO and BPO solutions to meet the growing desire of biopharma to outsource clinical operations functions in their entirety The viability of FSP as a scalable solution to nimbly adapt and navigate the challenges posed
